Gedela Srinubabu | |
|---|---|
 Gedela Srinubabu in 2019, Indian Delegation to Europe | |
| Born | Allena, Srikakulam, India |
| Alma mater | B.Pharma, MTech, PhD at Andhra University, and Post Doctorate at Stanford University |
| Occupation(s) | Scientist, industrialist |
| Employer(s) | CEO, OMICS Publishing Group |
| Title | Vice-President of Federation of Asian Biotech Association (FABA) and trade delegation of India to the European Union[1][2] |
| Website | www |
Gedela Srinubabu is an Indian businessman, scientist and politician. He is the founder and chief executive officer of the OMICS Publishing Group, a scientific journal publishing company that publishes science findings online for free,[3] and CEO of one of its subsidiary companies, Pulsus Group.
Srinubabu was the co-convenor of the Health, Pharma, and Tech Summit Series, executed across G20 countries to promote AI in healthcare and technology advancements. He is also an executive council member of Dr. B. R. Ambedkar University, Srikakulam.
OMICS' journals and conferences have been characterized as predatory publishing journals and predatory conferences with poor quality controls and a lack of legitimate services.[4][5][6] As a result of this business model, Srinubabu's journals have been banned from indexing within the National Institutes of Health's PubMed Central.[7] Additionally, in 2019, his company OMICS Publishing Group[8] was required to pay 50.1 million dollars in damages[9] following a US Federal Trade Commission complaint that the company was deceiving researchers[10] and the academicians.[11][12]
- ^ Cite error: The named reference
FABAwas invoked but never defined (see the help page). - ^ Cite error: The named reference
EuropeD2was invoked but never defined (see the help page). - ^ "Pulsus opens healthcare informatics, pharmacovigilance facility in Chennai". The Times of India. 9 March 2018.
- ^ Patnaik, Santosh (26 September 2012). "Chanting success mantra, scientific way". The Hindu. Archived from the original on 12 April 2021. Retrieved 30 October 2019.
{{cite news}}: CS1 maint: bot: original URL status unknown (link) - ^ "Scientific publisher Omics scripts major expansion; plans ₹1,000-cr investment". The Hindu. 16 January 2018. Retrieved 18 March 2022.
- ^ Deprez, Esmé E.; Chen, Caroline (29 August 2017). "Medical Journals Have a Fake News Problem". Bloomberg News. Archived from the original on 25 January 2019.
- ^ Roberts, William Clifford (1 February 2018). "Facts and ideas from anywhere". Baylor University. Vol. 31, no. 1. pp. 141–151. doi:10.1080/08998280.2017.1401850. PMC 5903519. PMID 29686586.
- ^ "FTC Charges Academic Journal Publisher OMICS Group Deceived Researchers". Federal Trade Commission. 26 August 2016. Retrieved 11 October 2023.
- ^ Prasad, R. (3 April 2019). "Hyderabad-based OMICS fined $50 million for 'unfair, deceptive business practices'". The Hindu. ISSN 0971-751X. Retrieved 11 October 2023.
- ^ "US court fines journal publisher USD 50 million for 'deceptive practices'". The Indian Express. 5 April 2019. Retrieved 11 October 2023.
- ^ "Cases and Proceedings - OMICS Group Inc". Federal Trade Commission. 26 August 2016.
- ^ "Hyderabad-Based OMICS Fined $50 Million for 'Deceptive Practices'". The Wire. Retrieved 11 October 2023.